Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trialsJohn G.F. Cleland, Karina V Bunting, Marcus Flather et al.|European Heart Journal|2017Cited by 643
Noncardiac Comorbidities in Heart Failure With Reduced Versus Preserved Ejection FractionRobert J. Mentz, Christopher M. O’Connor, Ewa A. Jankowska et al.|Journal of the American College of Cardiology|2014Cited by 541
Renin–Angiotensin Blockade Combined With Natriuretic Peptide System AugmentationThomas G. von Lueder, Henry Krum|Circulation Heart Failure|2013Cited by 128
Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart FailureDipak Kotecha, Andrew J.S. Coats, Simrat Gill et al.|Journal of the American College of Cardiology|2019Cited by 67